Press Release: Psycheceutical, Inc. Announces New Patents that Enable Psychedelic Compounds to be Administered as Pharmaceutical Medicines
Cannabis Law Report
AUGUST 22, 2021
a biotechnology company dedicated to the development and commercialization of psychedelic medicines, today announced its exclusive license within the entire psychedelic industry of two major patents that will significantly advance the medical application of psychedelic compounds. MIAMI , Aug. ” About Psycheceutical, Inc.
Let's personalize your content